Ausgabe 4/2016
Update on Pharmacological Agents for Management of Chronic Stable Angina
Inhalt (10 Artikel)
Overview of Management of Myocardial Ischemia: a Mechanistic-Based Approach
Gaetano Antonio Lanza, Filippo Crea
Treatment of Angina Pectoris Associated with Coronary Microvascular Dysfunction
Peter Ong, Anastasios Athanasiadis, Udo Sechtem
Beta-Blockers and Calcium Channel Blockers: First Line Agents
Isaac Pascual, Cesar Moris, Pablo Avanzas
Vasodilator Therapy: Nitrates and Nicorandil
Jason M. Tarkin, Juan Carlos Kaski
Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update
Giacinta Guarini, Alda Huqi, Doralisa Morrone, Mario Marzilli
Pharmacological Management of Chronic Stable Angina: Focus on Ranolazine
Giuseppe M. C. Rosano, Cristiana Vitale, Maurizio Volterrani
Drugs that Affect Cardiac Metabolism: Focus on Perhexiline
Cher-Rin Chong, Benedetta Sallustio, John D. Horowitz
The Role of Ivabradine in the Management of Angina Pectoris
Alessandra Giavarini, Ranil de Silva
Management of Stable Angina – Current Guidelines: A Critical Appraisal
Udho Thadani